More on BCDA

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (+37.5% Growth)
- Ratings (8.0 Score)

Upcoming Events

- Earnings (11/11/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

BioCardia (NQ:BCDA)
Delayed: 0.90 -0.02 (2.17%)
Prev. Close $0.92  
Open$0.93 
52 Wk High$0.17 
52 Wk Low$0.12 
Day High$0.93 
Day Low$0.86 
P/E N/A  
EPS$0.00 
Volume103,636 


Oct 20, 2026 05:42 PM Form 4 BioCardia, Inc. For: Oct 15 Filed by: Altman Peter
Oct 19, 2026 09:15 AM Form 8-K BioCardia, Inc. For: Oct 19
Oct 19, 2026 09:15 AM FDA accepts BioCardia's De Novo pre-submission for Helix catheter
Oct 19, 2026 09:15 AM BioCardia Announces FDA Acceptance of De Novo Pre-Submission Package for Helix™ Catheter Marketing Clearance FDA Substantive Review and Meeting Expected this Quarter
Oct 7, 2026 09:00 AM Form 8-K BioCardia, Inc. For: Oct 07
Oct 7, 2026 09:00 AM BioCardia Presents CardiAMP HF II Trial Design at Heart Failure Society of America Annual Scientific Meeting
Oct 1, 2026 09:15 AM Form 8-K BioCardia, Inc. For: Oct 01
Oct 1, 2026 09:15 AM BioCardia files revised De Novo pre-submission for Helix catheter
Oct 1, 2026 09:15 AM BioCardia Files Revised De Novo Pre-Submission for FDA Approval of Helix™ Catheter
Sep 30, 2026 06:52 PM Form 4 BioCardia, Inc. For: Sep 29 Filed by: Altman Peter
View All Articles

Entities mentioned with BCDA

View All Entities